Nuzenio

Capricor Therapeutics

Capricor Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 02:00:00 GMTCapricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR - PR Newswire
Fri, 07 Aug 2026 19:26:00 GMTCapricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - theglobeandmail.com
Fri, 07 Aug 2026 17:58:49 GMTDilution adjustment of Capricor Therapeutics, Inc. – HAM:4LN2 - TradingView
Fri, 07 Aug 2026 14:08:00 GMTCAPR Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
Fri, 07 Aug 2026 12:54:45 GMTState Street Corporation (NASDAQ: CAPR custodian) holds 5.9% of Capricor Therapeutics - Stock Titan
Fri, 07 Aug 2026 04:56:51 GMTCAPR Stock Gains Steam: Former Capricor Exec Could Become FDA’s Top Gene Therapy Regulator Ahead Of High-Stakes DMD Decision - Stocktwits

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Capricor Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.